The results indicated that HMGA2 expression was significantly upregulated in endometrial cancer, was significantly associated with poor clinical and pathological features of EC, and that patients with high HMGA2 expression had significantly decreased overall survival and disease-free survival rates. Here, HMGA2 is linked to endometrial cancer.